Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cerevel Therapeutics Inc...

    NASDAQ: CERE · Real-Time Price · USD
    44.96
    0.33 (0.74%)
    At close: Jul 31, 2024, 10:00 PM

    Cerevel Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 5.63M 4.9M 2.73M
    Gross Profit
    		 -5.63M -4.9M -2.73M
    Operating Income
    		 -447.26M -367.85M -220.1M
    Interest Income
    		 43.87M 9.62M 157K
    Pretax Income
    		 -432.34M -351.35M -225.33M
    Net Income
    		 -432.84M -351.51M -222.45M
    Selling & General & Admin
    		 112.62M 87.59M 58.24M
    Research & Development
    		 334.64M 280.26M 161.85M
    Other Expenses
    		 n/a 6.88M -5.39M
    Operating Expenses
    		 465.64M 367.85M 220.1M
    Interest Expense
    		 10.57M 9.62M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 465.64M 367.85M 220.1M
    Income Tax Expense
    		 503K 160K -2.89M
    Shares Outstanding (Basic)
    		 162.06M 151.27M 136.58M
    Shares Outstanding (Diluted)
    		 162.06M 151.27M 136.58M
    EPS (Basic)
    		 -2.67 -2.32 -1.63
    EPS (Diluted)
    		 -2.67 -2.32 -1.63
    EBITDA
    		 -441.64M -367.85M -211.98M
    EBIT
    		 -421.77M -341.73M n/a
    Depreciation & Amortization
    		 5.63M 4.9M 2.73M

    Add to Watchlist